[ Mon, Sep 16th 2024 ]: WOPRAI
[ Mon, Sep 16th 2024 ]: WOPRAI
[ Mon, Sep 16th 2024 ]: WOPRAI
[ Mon, Sep 16th 2024 ]: WOPRAI
[ Mon, Sep 16th 2024 ]: WOPRAI
[ Mon, Sep 16th 2024 ]: WOPRAI
[ Mon, Sep 16th 2024 ]: WOPRAI
[ Mon, Sep 16th 2024 ]: WOPRAI
[ Mon, Sep 16th 2024 ]: WOPRAI
[ Mon, Sep 16th 2024 ]: WOPRAI
[ Mon, Sep 16th 2024 ]: WOPRAI
[ Mon, Sep 16th 2024 ]: WOPRAI
[ Mon, Sep 16th 2024 ]: WOPRAI
[ Mon, Sep 16th 2024 ]: WOPRAI
[ Mon, Sep 16th 2024 ]: WOPRAI
[ Mon, Sep 16th 2024 ]: WOPRAI
[ Mon, Sep 16th 2024 ]: WOPRAI
[ Mon, Sep 16th 2024 ]: WOPRAI
[ Mon, Sep 16th 2024 ]: WOPRAI
[ Mon, Sep 16th 2024 ]: WOPRAI
[ Mon, Sep 16th 2024 ]: WOPRAI
[ Mon, Sep 16th 2024 ]: WOPRAI
[ Mon, Sep 16th 2024 ]: WOPRAI
[ Mon, Sep 16th 2024 ]: WOPRAI
[ Mon, Sep 16th 2024 ]: WOPRAI
[ Mon, Sep 16th 2024 ]: WOPRAI
[ Mon, Sep 16th 2024 ]: WOPRAI
[ Mon, Sep 16th 2024 ]: WOPRAI
[ Mon, Sep 16th 2024 ]: WOPRAI
[ Mon, Sep 16th 2024 ]: WOPRAI
[ Mon, Sep 16th 2024 ]: WOPRAI
[ Mon, Sep 16th 2024 ]: WOPRAI
[ Mon, Sep 16th 2024 ]: WOPRAI
[ Mon, Sep 16th 2024 ]: WOPRAI
[ Mon, Sep 16th 2024 ]: WOPRAI
[ Mon, Sep 16th 2024 ]: WOPRAI
[ Mon, Sep 16th 2024 ]: WOPRAI
[ Mon, Sep 16th 2024 ]: WOPRAI
[ Mon, Sep 16th 2024 ]: WOPRAI
[ Mon, Sep 16th 2024 ]: WOPRAI
[ Mon, Sep 16th 2024 ]: WOPRAI
[ Mon, Sep 16th 2024 ]: WOPRAI
[ Mon, Sep 16th 2024 ]: WOPRAI
[ Mon, Sep 16th 2024 ]: WOPRAI
[ Mon, Sep 16th 2024 ]: WOPRAI
[ Mon, Sep 16th 2024 ]: WOPRAI
[ Mon, Sep 16th 2024 ]: WOPRAI
[ Mon, Sep 16th 2024 ]: WOPRAI
Aydin Huseynov Upgraded (ACRV) to Strong Buy and Held Target at $16 on, Sep 16th, 2024
- 🞛 This publication is a summary or evaluation of another publication
Aydin Huseynov of Ladenburg Thalmann, Upgraded "Acrivon Therapeutics, Inc." (ACRV) to Strong Buy and Held Target at $16 on, Sep 16th, 2024.
Aydin, nor any peers, have made any analyst calls on ACRV in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30